REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/13/2026
Back to search
Official data from USPTO
THERAFLEX RX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
07/13/2026
Trademark type
Word
Nice classes
5
Filing date
03/17/2020
Registration date
07/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/13/2021
Last transaction
07/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/01/2010
First use in commerce
08/01/2012
Drawing code
4
Owner type
03
Owner location
Los Angeles, CA, US
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Supreme Enterprises International Corp
Representatives
Deborah J. Peckham Burns & Levinson, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements; Sports cream for relief of pain
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/13/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/27/2021
PUBO
PUBLISHED FOR OPPOSITION
04/27/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/24/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/20/2021
GNFR
FINAL REFUSAL E-MAILED
01/20/2021
CNFR
FINAL REFUSAL WRITTEN
01/20/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/17/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/17/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/17/2020
GNRT
NON-FINAL ACTION E-MAILED
06/17/2020
CNRT
NON-FINAL ACTION WRITTEN
06/17/2020
DOCK
ASSIGNED TO EXAMINER
06/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2020
NWAP
NEW APPLICATION ENTERED
03/20/2020
Continuous trademark protection
Get notified about every new filing that threatens THERAFLEX RX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.